| 000 | 01683 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518010240.0 | ||
| 264 | 0 | _c20191101 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1872-7980 | ||
| 024 | 7 |
_a10.1016/j.canlet.2018.11.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Meiling | |
| 245 | 0 | 0 |
_aIntratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity. _h[electronic resource] |
| 260 |
_bCancer letters _c02 2019 |
||
| 300 |
_a396-408 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 |
_aFibrillar Collagens _xbiosynthesis |
| 650 | 0 | 4 |
_aGelatin _xchemistry |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aInjections, Intralesional |
| 650 | 0 | 4 |
_aLosartan _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aPolyglutamic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aZhang, Chunxue | |
| 700 | 1 | _aTang, Zhaohui | |
| 700 | 1 | _aTang, Xing | |
| 700 | 1 | _aXu, Hui | |
| 773 | 0 |
_tCancer letters _gvol. 442 _gp. 396-408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2018.11.011 _zAvailable from publisher's website |
| 999 |
_c29054805 _d29054805 |
||